FDA clears a first-of-its-kind cholesterol pill for high-risk patients
The US Food and Drug Administration has approved a first-of-its-kind pill to lower cholesterol in patients at high risk of cardiovascular disease. The regulator assessed the drug under a programme offering ultra-fast reviews for promising medicines judged to serve the public interest.